Moreover, IHC staining for LPAR6 in two separate lung cancer cohorts with patients’ information was detected to analyze the correlation of the expression of LPAR6 and the clinicopathological parameters of lung cancer. This evidence concerns the gene LPAR6 and lung carcinoma.